CLINICAL_TRIALS
trial_result
· 2012-02-29
Clinical Trial Update: An Efficacy Study of Compound LY2624803 in the Treatment of Patients With Chronic Insomnia [Phase 2]
Summary
Phase 2 trial assessing the efficacy of LY2624803 for chronic insomnia (primary and secondary insomnia) has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Primary Insomnia, Secondary Insomnia | Phase 2 | Status: COMPLETED | Results posted: 2012-02-29